These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20191018)

  • 1. Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey.
    Oh CY; Lee SH; Yoo SJ; Chung BH
    Yonsei Med J; 2010 Mar; 51(2):248-52. PubMed ID: 20191018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.
    Lee SH; Kim DK; Kim JC; Lee KS; Lee JG; Park CH; Hong SJ; Kim CS; Park JK; Chung BH
    Yonsei Med J; 2010 May; 51(3):432-7. PubMed ID: 20376898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
    Paick JS; Kim SW; Ku JH
    Yonsei Med J; 2007 Apr; 48(2):281-8. PubMed ID: 17461528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors determining treatment strategies for patients with benign prostatic hyperplasia. The DUO study].
    Fourcade RO; Picot MC; Gaudin AF; Texier N; Slama A
    Presse Med; 2007 May; 36(5 Pt 1):755-63. PubMed ID: 17329070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database study.
    Park J; Lee YJ; Lee JW; Yoo TK; Chung JI; Yun SJ; Hong JH; Seo SI; Cho SY; Son H
    Korean J Urol; 2015 Mar; 56(3):233-9. PubMed ID: 25763128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of symptomatic BPH in Italy: who is treated and how?
    Tubaro A; Montanari E
    Eur Urol; 1999; 36 Suppl 3():28-32. PubMed ID: 10559628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
    Barry MJ; Fowler FJ; Bin L; Oesterling JE
    J Urol; 1997 Aug; 158(2):488-91; discussion 492. PubMed ID: 9224330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer. Canadian Prostate Health Council.
    Ramsey EW; Elhilali M; Goldenberg SL; Nickel CJ; Norman R; Perreault JP; Piercy B; Trachtenberg J
    J Urol; 2000 Feb; 163(2):499-502. PubMed ID: 10647665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.
    Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
    J Urol; 1995 Jul; 154(1):205-6. PubMed ID: 7539861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey on the Italian outpatient urologists regarding the management of benign prostatic hyperplasia.
    Magri V; Parazzini F; Chiaffarino F
    Arch Ital Urol Androl; 2006 Mar; 78(1):11-4. PubMed ID: 16752881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of medical treatment in benign prostatic hyperplasia.
    Kim CI; Chang HS; Kim BK; Park CH
    Urology; 2006 Nov; 68(5):1015-9. PubMed ID: 17095071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in International Prostate Symptom storage subscore after long-term medical therapy in BPH patients: finasteride and alpha-blocker combination therapy in men with moderate-to-severe LUTS/BPH in Korea.
    Lee JY; Lee SH; Kim SJ; Kim CS; Lee HM; Kim CI; Chung BH
    Urology; 2011 Jan; 77(1):171-6. PubMed ID: 20691464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Referral criteria for benign prostatic hyperplasia in primary care.Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina General, Sociedad Española de Medicina de Familia y Comunitaria, Asociación Española de Urología].
    Castiñeiras Fernández J; Cozar Olmo JM; Fernández-Pro A; Martín JA; Brenes Bermúdez FJ; Naval Pulido E; Molero JM; Pérez Morales D; ; ; ;
    Actas Urol Esp; 2010 Jan; 34(1):24-34. PubMed ID: 20223130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
    Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
    J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options.
    Sandhu JS; Vaughan ED
    Drugs Aging; 2005; 22(11):901-12. PubMed ID: 16323969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on current care guidelines: benign prostatic hyperplasia].
    Tammela T; Nurmi M; Pétas A; Sipilä R; Taari K
    Duodecim; 2012; 128(10):1046-7. PubMed ID: 22724320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.